# Manufacturer of Controlled Substances Registration: Johnson Matthey Pharmaceutical Materials, Inc.
**AGENCY:**
Drug Enforcement Administration, Department of Justice.
**ACTION:**
Notice of registration.
**SUMMARY:**
Johnson Matthey Pharmaceutical Materials, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Johnson Matthey Pharmaceutical Materials, Inc. registration as a manufacturer of the controlled substances.
**SUPPLEMENTARY INFORMATION:**
By notice dated January 15, 2014, and published in the *Federal Register* on February 4, 2014, 79 FR 6633, Johnson Matthey Pharmaceutical Materials, Inc., Pharmaceutical Service, 25 Patton Road, Devens, Massachusetts 01434, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.
The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances:
| Controlled substance | Schedule |
| --- | --- |
| Amphetamine (1100) | II |
| Methylphenidate (1724) | II |
| Nabilone (7379) | II |
| Hydrocodone (9193) | II |
| Alfentanil (9737) | II |
| Remifentanil (9739) | II |
| Sufentanil (9740) | II |
The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company's primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company's customers.
Dated: November 25, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.